These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15565127)

  • 21. [Effects of testosterone supplement therapy on multiple organs and systems and its action duration].
    Bai G; Li HJ
    Zhonghua Nan Ke Xue; 2013 Aug; 19(8):748-52. PubMed ID: 24010213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Testosterone replacement therapy faces FDA scrutiny.
    Garnick MB
    JAMA; 2015 Feb; 313(6):563-4. PubMed ID: 25502018
    [No Abstract]   [Full Text] [Related]  

  • 23. Testosterone replacement therapy: who to evaluate, what to use, how to follow, and who is at risk?
    Afiadata A; Ellsworth P
    Hosp Pract (1995); 2014 Dec; 42(5):69-82. PubMed ID: 25485919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Testosterone administration in older men.
    Matsumoto AM
    Endocrinol Metab Clin North Am; 2013 Jun; 42(2):271-86. PubMed ID: 23702401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation, treatment and monitoring of late-onset hypogonadism in males.
    Nieschlag E; Swerdloff R; Behre HM; Gooren LJ; Kaufman JM; Legros JJ; Lunenfeld B; Morley JE; Schulman C; Wang C; Weidner W; Wu FC
    Aging Male; 2005 Jun; 8(2):56-8. PubMed ID: 16096159
    [No Abstract]   [Full Text] [Related]  

  • 26. Influence of testosterone gel treatment on spermatogenesis in men with hypogonadism.
    George M; Yulia T; Svetlana K
    Gynecol Endocrinol; 2014 Oct; 30 Suppl 1():22-4. PubMed ID: 25200823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do we have enough evidences that make you safe to treat a man with hypogonadism one year after a radical prostatectomy for prostate cancer? | Opinion: Not Yet.
    Wroclawski ML; Heldwein FL
    Int Braz J Urol; 2018; 44(1):8-13. PubMed ID: 29424507
    [No Abstract]   [Full Text] [Related]  

  • 28. Testosterone replacement in elderly men.
    Baum NH; Crespi CA
    Geriatrics; 2007 Sep; 62(9):15-8. PubMed ID: 17824721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do we have enough evidences that make you safe to treat a man with hypogonadism one year after a radical prostatectomy for prostate cancer? | Opinion: YES.
    Torres LO
    Int Braz J Urol; 2018; 44(1):4-7. PubMed ID: 29424506
    [No Abstract]   [Full Text] [Related]  

  • 30. The testosterone storm.
    Gomella LG
    Can J Urol; 2015 Apr; 22(2):7677. PubMed ID: 25891328
    [No Abstract]   [Full Text] [Related]  

  • 31. Testosterone replacement therapy to improve health in older males.
    Baer JT
    Nurse Pract; 2012 Aug; 37(8):39-44. PubMed ID: 22842141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging medication for the treatment of male hypogonadism.
    Aydogdu A; Swerdloff RS
    Expert Opin Emerg Drugs; 2016 Sep; 21(3):255-66. PubMed ID: 27552127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel Therapy for Male Hypogonadism.
    Carrasquillo R; Chu K; Ramasamy R
    Curr Urol Rep; 2018 Jun; 19(8):63. PubMed ID: 29886559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular Safety of Testosterone-Replacement Therapy: Critical Appraisal of a Currently Published Clinical Trial.
    Muller IT; Decker SRDR; Rosa RG; Rollin G
    Arq Bras Cardiol; 2024; 121(3):e20230558. PubMed ID: 38695467
    [No Abstract]   [Full Text] [Related]  

  • 35. Testosterone topical solution (Axiron) for hypogonadism.
    Med Lett Drugs Ther; 2011 Jul; 53(1368):54-5. PubMed ID: 21738108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Testosterone substitution in patients with hypogonadism].
    Martínez Portillo FJ; Cueva Martínez A; Martin Braun P; Fernández Arancibia MI; Jünemann KP; Alken P
    Arch Esp Urol; 2002 Sep; 55(7):827-38. PubMed ID: 12380312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Testosterone replacement therapy and prostate cancer: the downfall of a paradigm?].
    Castillo OA; López-Fontana G; Vidal-Mora I; López Laur JD
    Medwave; 2015 Apr; 15(3):e6115. PubMed ID: 25919660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FPIN's clinical inquiries. Testosterone therapy and risk recurrence after treatment of prostate cancer.
    Meza J; Weaver K; Martin S
    Am Fam Physician; 2013 Oct; 88(8):Online. PubMed ID: 24364582
    [No Abstract]   [Full Text] [Related]  

  • 39. [Testosterone therapy].
    Diemer T; Hauptmann A; Wagenlehner FM
    Urologe A; 2016 Apr; 55(4):539-48; quiz 549-50. PubMed ID: 27067659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Testosterone substitution with special regard to prostate cancer].
    Beintker M; Behre H
    Urologe A; 2008 Dec; 47(12):1588-91. PubMed ID: 18931991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.